AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35035849 — intervention group
Group type: COMPARATOR
Intervention: Ketamine anesthesia (control group)
Number of subjects: 100
Study 33220095 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral melatonin
Number of subjects: 20
Study 33220095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36474274 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine (PQ) alongside standard artemisinin‐based combination therapy (ACT)
Number of subjects: 100
Study 36474274 — intervention group
Group type: COMPARATOR
Intervention: Standard artemisinin‐based combination therapy (ACT) without primaquine
Number of subjects: 100
Study 36474274 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without residual gametocytes)
Number of subjects: 100
Study 32389224 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency denervation combined with a standardized exercise program
Number of subjects: 681
Study 32389224 — intervention group
Group type: COMPARATOR
Intervention: Standardized exercise program alone
Number of subjects: 681
Study 34274921 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine prolong 80 mg once daily
Number of subjects: 1670
Study 36253032 — intervention group
Group type: EXPERIMENTAL
Intervention: YLB113 (50 mg subcutaneously every 2 weeks)
Number of subjects: 201
Study 36253032 — intervention group
Group type: EXPERIMENTAL
Intervention: YLB113
Number of subjects: 201
Study 32080797 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light (BL) therapy for 45 minutes for 4 weeks
Number of subjects: 18
Study 32080797 — intervention group
Group type: COMPARATOR
Intervention: Dim Light (DL) therapy for 45 minutes for 4 weeks
Number of subjects: 18
Study 32763649 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-session parenting program delivered by local community members
Number of subjects: 552
Study 32763649 — intervention group
Group type: COMPARATOR
Intervention: Control group received a brief informational workshop
Number of subjects: 552
Study 35344046 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral laminotomy with crossover
Number of subjects: 437
Study 35344046 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral laminotomy
Number of subjects: 437
Study 35344046 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinous process osteotomy
Number of subjects: 437
Study 33060490 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with low tidal volume (LTV; 6-8 mL/kg)
Number of subjects: 82
Study 33060490 — intervention group
Group type: COMPARATOR
Intervention: Conventional tidal volume (CTV; 10-12 mL/kg)
Number of subjects: 82
Study 32610511 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Kinetic Chain Exercise (OKCE)
Number of subjects: 26
Study 32610511 — intervention group
Group type: COMPARATOR
Intervention: Closed Kinetic Chain Exercise (CKCE)
Number of subjects: 26
Study 35435086 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 g of boiled walnut taken daily as snacks
Number of subjects: 45
Study 33373480 — intervention group
Group type: EXPERIMENTAL
Intervention: brodalumab 210 mg Q2W
Number of subjects: 62
Study 33373480 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 62
Study 36082590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab
Number of subjects: 2285
Study 36082590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2285
Study 32438817 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 32438817 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 0
Study 33314496 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-restriction therapy (SRT)
Number of subjects: 18
Study 35971080 — intervention group
Group type: EXPERIMENTAL
Intervention: Trachway® flexible stylet
Number of subjects: 108
Study 35971080 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 108
Study 35971080 — intervention group
Group type: COMPARATOR
Intervention: Flexible fiberoptic bronchoscopy
Number of subjects: 108
Study 33472269 — intervention group
Group type: EXPERIMENTAL
Intervention: Prethrombectomy blood pressure management
Number of subjects: 0
Study 33472269 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-recanalization blood pressure management
Number of subjects: 0
Study 35105176 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-Eluting Envelope (AEE)
Number of subjects: 0
Study 35105176 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34220999 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed machine learning-based network IDS using SMOTE and Extremely Randomized Trees Classifier
Number of subjects: 0
Study 36239611 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib with nivolumab and ipilimumab
Number of subjects: 0
Study 36239611 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0
Study 34563178 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 0
Study 34655181 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol (10 μg/kg/min)
Number of subjects: 16
Study 34655181 — intervention group
Group type: COMPARATOR
Intervention: Esmolol (50 μg/kg/min)
Number of subjects: 16
Study 33723649 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (maintaining telephone contacts and providing educational materials)
Number of subjects: 91
Study 33723649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telehealth intervention)
Number of subjects: 91
Study 33723649 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 91
Study 33723649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study 33460319 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz tACS
Number of subjects: 33
Study 33460319 — intervention group
Group type: COMPARATOR
Intervention: 20 Hz tACS
Number of subjects: 33
Study 33460319 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 33
Study 33432829 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein isolate (19.2 g/day for 18 months)
Number of subjects: 0
Study 33432829 — intervention group
Group type: COMPARATOR
Intervention: Casein-based placebo
Number of subjects: 0
Study 32660762 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyhance EDOF monofocal IOL
Number of subjects: 30
Study 32660762 — intervention group
Group type: COMPARATOR
Intervention: TECNIS 1‐piece IOL
Number of subjects: 30
Study 35060070 — intervention group
Group type: EXPERIMENTAL
Intervention: Undergraduate experiential learning course
Number of subjects: 56
Study 35060070 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in translational research team meetings and events
Number of subjects: 56
Study 35060070 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentorship activities including graduate student theses and supplementary projects
Number of subjects: 56
Study 33211212 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly teriparatide (56.5 µg)
Number of subjects: 180
Study 33211212 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly alendronate (35 mg)
Number of subjects: 180
Study 32012080 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based education intervention
Number of subjects: 310
Study 32012080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 310
Study 35978374 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) prior to speech-language therapy
Number of subjects: 48
Study 35978374 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) concurrent with speech-language therapy
Number of subjects: 48
Study 35978374 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) following speech-language therapy
Number of subjects: 48
Study 35978374 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (speech-language therapy only)
Number of subjects: 48
Study 33539554 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based exercise intervention
Number of subjects: 213
Study 33539554 — intervention group
Group type: COMPARATOR
Intervention: Support group
Number of subjects: 213
Study 32323640 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (12 weeks, 3 days/week, 60 min/session)
Number of subjects: 31
Study 32323640 — intervention group
Group type: COMPARATOR
Intervention: Center-based exercise program (12 weeks, 3 days/week, 60 min/session)
Number of subjects: 31
Study 34930614 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning (iPOST) in addition to primary percutaneous coronary intervention (PCI) without thrombectomy
Number of subjects: 1234
Study 34930614 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary percutaneous coronary intervention (PCI) without thrombectomy
Number of subjects: 1234
Study 34930614 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic postconditioning (iPOST) in addition to primary percutaneous coronary intervention (PCI) with thrombectomy
Number of subjects: 1234
Study 34930614 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary percutaneous coronary intervention (PCI) with thrombectomy
Number of subjects: 1234
Study 34208742 — intervention group
Group type: EXPERIMENTAL
Intervention: Bis-Hexanoyl (R)-1,3-Butanediol (BH-BD) 12.5 g (Days 0–7) and 25 g (Days 7–28)
Number of subjects: 59
Study 34208742 — intervention group
Group type: EXPERIMENTAL
Intervention: Bis-Hexanoyl (R)-1,3-Butanediol (BH-BD)
Number of subjects: 59
Study 34208742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 34766787 — intervention group
Group type: EXPERIMENTAL
Intervention: Label (mental illness called schizophrenia)
Number of subjects: 1481
Study 34766787 — intervention group
Group type: COMPARATOR
Intervention: No label condition
Number of subjects: 1481
Study 33683337 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem Fluzone High-Dose vaccination (2 doses)
Number of subjects: 122
Study 33683337 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care vaccination (single-dose)
Number of subjects: 122
Study 32859638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs)
Number of subjects: 42
Study 32859638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) with concurrent resistance mutation
Number of subjects: 42
Study 32859638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) without concurrent mutations
Number of subjects: 42
Study 32859638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors (TKIs) with non-pathogenic, non-resistance co-mutation
Number of subjects: 42
Study 35073496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-focus soft contact lenses
Number of subjects: 24
Study 35073496 — intervention group
Group type: COMPARATOR
Intervention: Single-vision soft contact lenses
Number of subjects: 24
Study 34363216 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization (PCI or CABG)
Number of subjects: 1015
Study 34363216 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1015
Study 32552472 — intervention group
Group type: EXPERIMENTAL
Intervention: ABFM C-MTX regimen
Number of subjects: 299
Study 32552472 — intervention group
Group type: COMPARATOR
Intervention: Nelarabine (for high-risk patients)
Number of subjects: 299
Study 36266613 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol 0.5% (w/w) applied twice daily for 6 weeks
Number of subjects: 64
Study 36266613 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol 0.5% (w/w)
Number of subjects: 64
Study 36266613 — intervention group
Group type: COMPARATOR
Intervention: Placebo topical gel
Number of subjects: 64
Study 34001053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF) measured by the six-minute running/walking test
Number of subjects: 2418
Study 32062677 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity instructions
Number of subjects: 146
Study 32062677 — intervention group
Group type: COMPARATOR
Intervention: Restricted postoperative activity instructions
Number of subjects: 146
Study 616673046 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of IR‐A and MEL
Number of subjects: 123
Study 616673046 — intervention group
Group type: COMPARATOR
Intervention: IR‐A
Number of subjects: 123
Study 616673046 — intervention group
Group type: COMPARATOR
Intervention: MEL
Number of subjects: 123
Study 34038230 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention
Number of subjects: 200
Study 34038230 — intervention group
Group type: COMPARATOR
Intervention: Individual burden indicators and neighborhood crime density
Number of subjects: 200
Study 34840756 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar electrosurgery
Number of subjects: 20
Study 34840756 — intervention group
Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 20
Study 33657083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 190
Study 33657083 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 190
Study 32530518 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural bolus
Number of subjects: 130
Study 32530518 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia
Number of subjects: 130
Study 32530518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study 36284454 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus sheath block (RSB) with fentanyl PCA
Number of subjects: 36
Study 36284454 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) alone
Number of subjects: 36
Study 36284454 — intervention group
Group type: EXPERIMENTAL
Intervention: Nausea/vomiting score
Number of subjects: 36
Study 36284454 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional analgesic consumption
Number of subjects: 36
Study 33421456 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention (3 text messages per week for 6 months)
Number of subjects: 130
Study 33421456 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary care (control group)
Number of subjects: 130
Study 83020338 — intervention group
Group type: EXPERIMENTAL
Intervention: apomorphine (5 mg)
Number of subjects: 12
Study 83020338 — intervention group
Group type: EXPERIMENTAL
Intervention: amantadine (200 mg)
Number of subjects: 12
Study 83020338 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 35245844 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 0
Study 35245844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32321680 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HFRT)
Number of subjects: 5190
Study 33687496 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 Y chromosomal genetic markers
Number of subjects: 202
Study 32299679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 66
Study 32299679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy (randomized arm)
Number of subjects: 66
Study 32299679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy (open-label comparison)
Number of subjects: 66
Study 32299679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy (combined analysis)
Number of subjects: 66
Study 34801952 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced walking
Number of subjects: 18
Study 34801952 — intervention group
Group type: COMPARATOR
Intervention: Fixed-paced walking
Number of subjects: 18
Study 33287716 — intervention group
Group type: EXPERIMENTAL
Intervention: EDDIE program (hospital avoidance initiative)
Number of subjects: 96
Study 35301512 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vedolizumab (100 or 150 mg for patients <30 kg; 200 or 300 mg for patients ≥30 kg)
Number of subjects: 88
Study 35301512 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vedolizumab (100 or 150 mg for patients <30 kg; 200 or 300 mg for patients ≥30 kg)
Number of subjects: 88
Study 35301512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both low and high-dose vedolizumab
Number of subjects: 88
Study 32357854 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-free-chop technique (Group 1)
Number of subjects: 60
Study 32357854 — intervention group
Group type: COMPARATOR
Intervention: Phaco-chop technique (Group 2)
Number of subjects: 60
Study 34861036 — intervention group
Group type: EXPERIMENTAL
Intervention: Third BNT162b2 mRNA vaccine dose
Number of subjects: 172
Study 34357348 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI Gel
Number of subjects: 4
Study 34357348 — intervention group
Group type: COMPARATOR
Intervention: MCI Drink
Number of subjects: 4
Study 34357348 — intervention group
Group type: COMPARATOR
Intervention: Hom. Cheese
Number of subjects: 4
Study 34357348 — intervention group
Group type: COMPARATOR
Intervention: Cheese
Number of subjects: 4
Study 35997659 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 1 (Moderate Frequency, Moderate Pain)
Number of subjects: 62
Study 35997659 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 2 (Almost Daily, High Pain)
Number of subjects: 62
Study 33951060 — intervention group
Group type: EXPERIMENTAL
Intervention: Isothermal loop‐mediated amplification (LAMP) assay using saliva samples
Number of subjects: 0
Study 33951060 — intervention group
Group type: COMPARATOR
Intervention: Standard RT-qPCR tests
Number of subjects: 0
Study 32220372 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D for 12 weeks
Number of subjects: 50
Study 32220372 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/day vitamin D for 12 weeks
Number of subjects: 50
Study 35460441 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER-SMS
Number of subjects: 160
Study 35460441 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study 34606123 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal remedies (polyherbal decoction every 8 hr and two herbal capsules every 12 hr) plus standard care for 7 days
Number of subjects: 358
Study 34606123 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 358
Study 32977683 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative format
Number of subjects: 151
Study 32977683 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic format
Number of subjects: 151
Study 32977683 — intervention group
Group type: COMPARATOR
Intervention: No information control group
Number of subjects: 151
Study 34427066 — intervention group
Group type: EXPERIMENTAL
Intervention: New mortality scoring system based on demographic factors and laboratory findings
Number of subjects: 1232
Study 33064025 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for 2 weeks
Number of subjects: 261
Study 33064025 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for 4 weeks
Number of subjects: 261
Study 33064025 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for longer than 4 weeks
Number of subjects: 261
Study 33494301 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic obedience training class
Number of subjects: 41
Study 33494301 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 41
Study 32360596 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (200,000 IU initially, then 100,000 IU monthly)
Number of subjects: 5110
Study 32360596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5110
Study 35275023 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 28.8 min)
Number of subjects: 27
Study 35275023 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study 33215265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-strengthening self-exercises (TSsE) using a tongue-strengthening self-exercise tool, 30 repetitions, 3 times a day, 5 days a week for 8 weeks
Number of subjects: 27
Study 33215265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-strengthening self-exercises (TSsE) using a tongue-strengthening self-exercise tool
Number of subjects: 27
Study 33215265 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to TSsE
Number of subjects: 27
Study 33215265 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 27
Study 33083489 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin gel with scaling and root planing (SRP) for 7 days
Number of subjects: 90
Study 33083489 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 90
Study 34034143 — intervention group
Group type: EXPERIMENTAL
Intervention: IN-MLV (n = 11): 2 mL of IN MLV vaccine containing BHV1, BRSV, and BPI3V (Inforce3®)
Number of subjects: 21
Study 34034143 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-MLV (n = 10): 2 mL of MLV vaccine containing BHV1, BRSV, BPI3V, and BVDV1 & 2 (Bovi-Shield GOLD® 5)
Number of subjects: 21
Study 34034143 — intervention group
Group type: COMPARATOR
Intervention: Both IN and SC booster vaccination
Number of subjects: 21
Study 35562804 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 208
Study 35562804 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 208
Study 35562804 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (total risk score of ≥ 6.5 points)
Number of subjects: 208
Study 32248552 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 80
Study 32248552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33433264 — intervention group
Group type: EXPERIMENTAL
Intervention: Email plus phone coaching (coaching condition)
Number of subjects: 136
Study 33433264 — intervention group
Group type: COMPARATOR
Intervention: Email prompts alone (non‐coaching condition)
Number of subjects: 136
Study 32250470 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg)
Number of subjects: 24